Assessment of the tumor-infiltrating CD8+ T cells revealed no significant change in CD8+ T cell numbers within the tumor stroma regardless of Pdl1 deletion in tumor cells or with PD-L1–blocking antibodies (Figure 1B). This evidence concerns the gene CD8A and neoplasm.